Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 1 1

Status

Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Genitourinary 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 8Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 3Hematologic Neoplasms 3Neoplasms by Site 2Neoplasms by Histologic Type 2Lymphoproliferative Disorders 2Lymphoma, Large-Cell, Anaplastic 2Sexual Dysfunction, Physiological 1Rare Tumor 1Neuroblastoma 1Lymphoma 1Lung Diseases 1Eunuchism 1Erectile Dysfunction 1Colorectal Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Cyclophosphamide 3Biopsy 3sodium-iodide symporter 2fludarabine 2cemiplimab 2alectinib 2X-Rays 2Stem Cell Transplantation 2Photons 2Nivolumab 2Ipilimumab 2Immunoglobulin G 2Disulfides 2CTLA-4 Antigen 2treosulfan 1sargramostim 1ruxolitinib 1repotrectinib 1duvelisib 1brigatinib 1belinostat 1Whole-Body Irradiation 1Vinblastine 1Suspensions 1Standard of Care 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Mycophenolic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Lymphoma, Large-Cell, Anaplastic × alectinib × Clear all
NCT07001384 2026-05-26

A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
30 enrolled
Lymphoid

Lymphoma, Large-Cell, Anaplastic

NCT05770037 2025-11-24

DETERMINE

Cancer Research UK

Phase 2/3 Recruiting
30 enrolled
CNSGenitourinaryLymphoidOther hematologic neoplasm

Carcinoma, Renal Cell, Lymphoma, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neuroblastoma, Lymphoma, Large-Cell, Anaplastic, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡